PT Anugrah Argon Medica (AAM) participated in the Annual Scientific Meeting (PIT) and National Congress (MUNAS) of the Indonesian Hospital Pharmacy Seminar Association (HISFARSI) held in Palembang, South Sumatra. During the Pharmacy Update session on the third day of the event, Saturday, May 27, 2023, Mrs. Sulviria, S.Pharm, AAM's Quality Assurance Manager, delivered a presentation titled "Distribution of Pharmaceutical Precursors to Hospital Service Facilities."
The distribution of pharmaceutical precursors in distribution facilities is regulated by the regulations of the Indonesian National Agency of Drug and Food Control (BPOM), namely: BPOM Regulation No. 24 of 2021 on the Supervision of Management of Drugs, Medicinal Materials, Narcotics, Psychotropics, and Pharmaceutical Precursors in Pharmaceutical Service Facilities; and BPOM Regulation No. 6 of 2020 on Amendments to BPOM Regulation No. 09 of 2019 on Technical Guidelines for Good Distribution Practices.
Both hospitals and Wholesale Pharmaceutical Traders have a list of obligations that must be fulfilled. "Challenges often encountered in the distribution of precursor products in hospitals need to be addressed by all of the pharmacists, so that the distribution of precursors from Wholesale Pharmaceutical Traders to hospitals can run smoothly," Mrs. Sulviria explained to almost thousands of pharmacists in attendance from across Indonesia.
Furthermore, she highlighted four commonly encountered challenges: accuracy of purchase orders, validity of purchase orders, receiving personnel at the facilities, and analysis of reasonableness and payment.
During her presentation, Mrs. Sulviria also explained information about ordering letters based on the BPOM format and customer qualification. "We are obliged to qualify our customers to ensure that the products are distributed to authorized parties," she stated.
As a healthcare product distribution company with over 42 years of experience, AAM maintains the trust of its partners and consumers by complying with and adhering to BPOM Regulation No. 6 of 2020 regarding customer qualification. Distribution facilities must ensure that medicines are only distributed to authorized parties for delivery to the public. Proof of Customer Qualification must be well-documented. Periodic inspections and re-evaluations may include, but are not limited to, requests for copies of customer permits.
"Distribution facilities must monitor every transaction conducted and investigate any deviations or patterns of transactions that pose a risk of misuse, as well as ensure the obligation of providing drug distribution services to the public is fulfilled," concluded Mrs. Sulviria.